Impact Factor
7.883
Call For Paper
Volume 12 Issue 07
July 2026
Author(s)
Jitendra Kumar Shubhangini Robin Soni
Abstract
The Complexities At Various Levels Places Great Challenges To Biopharmaceutical Industry For Manufacturing Safe And Effective Biosimilar Product. Over The Last Few Years, The Industry Has Shifted Its Production Towards Mammalian Expression System Along Wi
Keywords
Biosimilar
Cell Lines
Expression Platforms
CRISPR
DoE
Glycosylation
Mammalian Process
TALEN
QbD
Paper ID
IJSARTV5I229383
Publication Date
February 17, 2019
Research Area
Biopharmaceuticals